Designs and manufactures fire apparatus equipment. Produces ambulances and emergency vehicles. Now — the numbers.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
This is an established company with proven profits.
No real growth (1% a year).
The gap is $21.4M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 32.8× for every dollar this company earns in a year — a price that already assumes things go well.
Analysts' average target sits 47% below today's price.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
R&D Investment: Spending on future research is low.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.
It pays out $0.24 per share each year — regular cash for whoever holds the stock.
Over the last 4 years, sales grew only 1% a year on average. At this size, speeding back up is not easy.
The company’s market value is 33 times its annual profit. Even a small disappointment could hit the price hard.
The stock trades 47% above the average analyst price target.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.